Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (37)

2025

  1. Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction

    The New England journal of medicine, Vol. 393, Núm. 19, pp. 1889-1900

  2. Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trial

    The Lancet Regional Health - Europe, Vol. 55

  3. Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation

    The New England journal of medicine, Vol. 392, Núm. 14, pp. 1396-1405

  4. Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

    Journal of the American College of Cardiology, Vol. 86, Núm. 15, pp. 1128-1138

  5. JNK1 in SF1 neurons regulates the central action of thyroid hormones on hepatic lipid metabolism

    Molecular Metabolism, Vol. 98

  6. Use of the win ratio approach to assess outcomes in the DapaTAVI trial

    Revista Espanola de Cardiologia

2024

  1. Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)

    European Journal of Heart Failure, Vol. 26, Núm. 9, pp. 1999-2007

  2. Colchicine in acutely decompensated heart failure: the COLICA trial

    European Heart Journal, Vol. 45, Núm. 45, pp. 4826-4836

  3. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study

    European Journal of Heart Failure, Vol. 26, Núm. 4, pp. 776-784

  4. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

  5. p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway

    Cell Reports Medicine, Vol. 5, Núm. 2

2023

  1. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  2. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study

    European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360

  3. Results from the ACI-SEC Infarction Code Registry. The ECG also exists. Response

    Revista Espanola de Cardiologia

2022

  1. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

    European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330

  2. Analysis of the management of ST-segment elevation myocardial infarction in Spain. Results from the ACI-SEC Infarction Code Registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 669-680

  3. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: Part 2-care pathways, treatment, and follow-up

    Cardiovascular Research, Vol. 118, Núm. 7, pp. 1618-1666

  4. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

    European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103

  5. Environmental factors like air pollution: not to be forgotten in the 2021 ESC guidelines on heart failure. Response

    Revista Espanola de Cardiologia

  6. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412